|Institutional Source||Beutler Lab|
|Gene Name||major vault protein|
|Synonyms||LRP, VAULT1, 2310009M24Rik|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||R0812 (G1)|
|Chromosomal Location||126986860-127014621 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||G to A at 126987556 bp|
|Amino Acid Change||Alanine to Valine at position 801 (A801V)|
|Ref Sequence||ENSEMBL: ENSMUSP00000127250 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000165096]|
|Predicted Effect||probably benign
AA Change: A801V
PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
AA Change: A801V
|Meta Mutation Damage Score||0.12|
|Coding Region Coverage||
|Validation Efficiency||96% (52/54)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes the major component of the vault complex. Vaults are multi-subunit ribonucleoprotein structures that may be involved in nucleo-cytoplasmic transport. The encoded protein may play a role in multiple cellular processes by regulating the MAP kinase, JAK/STAT and phosphoinositide 3-kinase/Akt signaling pathways. The encoded protein also plays a role in multidrug resistance, and expression of this gene may be a prognostic marker for several types of cancer. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]
PHENOTYPE: Targeted disruption of this gene does not induce hypersensitivity to various cytostatic agents. Homozygotes are viable, healthy and phenotypically normal and exhibit unimpaired dendritic cell maturation and function. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Mvp||
(F):5'- TCATCGCACAGTGCTCAGTGAC -3'
(R):5'- TCCAAGGCTTGAATCGCAGGAC -3'
(F):5'- ACAGTGCTCAGTGACAGGTC -3'
(R):5'- cctgagattcccttctgcc -3'